Skip to content
MomMetabolicEVIDENCE-FIRST METABOLIC HEALTH
Menu
Grade C

Maves review

Written by Elena Voss, Metabolic Health Editor

Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.

Maves advertises semaglutide at $189 for the first month, then $249 a month, and tirzepatide at $249 first month, then $349. Treatment availability varies by state.

$249/mo
Flat price · every dose
Consult Medication Shipping Coaching
See plans at Maves
  • Confirm HSA / FSA coverage
  • Public information reviewed
  • Confirm your total cost
Compare alternatives ↓

Maves at a glance

Semaglutide
$249/mo after $189 first month
Tirzepatide
$349/mo after $249 first month
Coverage
Select U.S. states; treatment availability varies by state
Brand-name
Compounded only

How we scored Maves

Every factor comes from Maves's own published pricing, disclosures and oversight, and the six combine into the 34/100 Metabolic-Fit Score on our weighted six-factor framework. Commissions don't change a provider's score.

Postpartum & breastfeeding guidance10/100 · Weak

No postpartum or breastfeeding framing — a generic weight program.

PCOS & hormonal fit15/100 · Weak

Thin on the hormonal picture that drives many mothers' weight.

Clinical oversight & labs60/100 · Weak

Oversight and lab support fall short of the best on our list — the review below says exactly where.

True monthly cost55/100 · Weak

Cost is unpredictable or sits at the premium end.

Ongoing support45/100 · Weak

Support is thin once the prescription ships.

Cancellation fairness25/100 · Weak

Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.

How we checked this review

Maves advertises semaglutide at $189 for the first month, then $249 a month, and tirzepatide at $249 first month, then $349. Treatment availability varies by state.

Before you sign up

What Maves's public site and signup page show before you hand over any details.

Worth knowing

  • Homepage hero banner and the dedicated GLP-1 treatment card show two different starting prices ($99 first month vs. $89/month) for what appears to be the same program
  • Tirzepatide is listed in the site nav alongside semaglutide, but has no separately disclosed price anywhere on the public site
  • Site states pricing is all-inclusive: consult, medication, clinical support, and free shipping, with no separate membership fee
  • LegitScript certification badge found on-site; parent brand Homera Health disclosed via footer/login links
  • "Maves Clinicians are Licensed in all 50 States (Excludes U.S. territories)" is stated verbatim on-site — genuinely nationwide reach, more than most peers
  • LegitScript certification is a real, verifiable trust signal that most compounded-GLP-1 storefronts don't carry
  • The site's own two different starting-price claims ($99 vs $89) for the same GLP-1 program is a real, unresolved inconsistency, not a technicality
  • Tirzepatide is offered but never priced separately anywhere on the public site — readers cannot compare it against semaglutide before intake
  • Nothing on the site addresses pregnancy, breastfeeding, postpartum timing, or PCOS specifically

Pricing

MedicationPricePlan
Compounded semaglutide$249Month-to-month recurringFirst month $189, then $249/month.
Compounded tirzepatide$349Month-to-month recurringFirst month $249, then $349/month.

Swipe the table to see plan details →

Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what Maves's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.

What we like

  • LegitScript-certified — a real, checkable trust signal most peers don't carry
  • Both medication pages disclose the first-month and ongoing monthly charges.

The caveats

  • Nothing on the site addresses pregnancy, breastfeeding, postpartum timing, or PCOS
  • No cancellation policy disclosed on the public site

The second-month price is the useful comparison

Maves separates its opening offer from its recurring charge: compounded semaglutide costs $189 for the first month, then $249 a month; compounded tirzepatide costs $249 initially, then $349. Those are two different ongoing budgets, even though the first tirzepatide payment equals the regular semaglutide payment. Someone choosing between the drugs should compare $249 with $349 after the introductory month, then discuss clinical suitability separately. The cheaper opening month does not determine which prescription is appropriate.

The dedicated medication pages make that distinction much clearer than a single “starting at” banner would. What still needs confirmation is how the published rate applies to the intended dose and supply, and whether anything changes during continued treatment. Maves has described its program as including the consultation, medication, clinical support and shipping without a separate membership fee. Obtain the selected program's inclusions with the recurring price, especially if moving from another provider with a different formulation or shipment schedule.

Coverage has to be settled before intake

Maves now describes treatment as available in selected states, with availability varying by state. A nationwide clinician network should therefore not be read as permission to prescribe every treatment everywhere. Before completing a health questionnaire, establish whether the company serves the state where the consultation will occur and where medication will be delivered. A mother traveling between homes or spending several weeks with family needs an answer about those actual locations, rather than a general statement about national reach.

The service identifies Homera Health through its footer and login connections and displays a LegitScript badge. Those disclosures provide more accountability than an anonymous medication storefront, but they answer different questions from prescribing quality or pharmacy selection. A displayed badge does not make a compounded medicine FDA-approved or establish a particular clinician's experience with PCOS or postpartum care. Ask who will write the prescription, which pharmacy will prepare it, and how questions about the prescription reach that clinician after the initial assessment.

A clear price does not replace the missing care details

Maves does not publish a developed explanation of pregnancy, breastfeeding, postpartum timing or PCOS care. That absence is especially relevant if weight changes overlap with a recent birth, a planned pregnancy, cycle changes or an existing hormonal diagnosis. It leaves the prospective patient needing a personalized discussion rather than a women-specific program to evaluate beforehand. Clinical support is more useful when its scope is concrete: who responds, which concerns need an appointment, and how an outside obstetric or primary-care clinician can participate.

Cancellation is another unresolved part of the purchase. A lower first payment says little about the deadline for avoiding the next one or what happens once a prescription has been sent for dispensing. Request the renewal date, stopping procedure, refund limits and any shipping charges in writing before paying. Maves is easiest to consider for someone who can afford its regular $249 or $349 charge, confirms state eligibility early, and receives satisfactory answers about continued care. Its current price structure is understandable; the decision still depends on service and exit terms that the headline cannot supply. The first-month saving is $60 on semaglutide and $100 on tirzepatide, so its impact is concentrated at enrollment rather than spread across ongoing care.

The bottom line for mothers

Best for: Readers comparing these treatment options who can confirm the full plan total and renewal terms before enrolling.

Alternatives to Maves

These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.

  • CoreAge RxFeatured partner

    CoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.

    Visit CoreAge Rx
  • Bodybuilding Health+ does the disclosure part better than most of this market and the branding part more loosely. It names four compounding pharmacies outright with phone numbers, and it names two lead physicians with their NPI numbers — both of whom check out as active MDs in the federal registry. Pricing is flat at every dose and public before any intake: $179 a month for compounded semaglutide and $209 for tirzepatide, dropping to about $142 and $175 only if you buy a bundle up front. The looser part is the name. The operator is Dynamo Group LLC of Boca Raton, not Bodybuilding.com, and the 'trusted by millions since 1999' line on the page is the licensor's heritage rather than the clinic's. It's compounded-only, so there's no FDA-approved Wegovy or Zepbound route, the bundle discounts come with no published refund terms, and a prominent '4.8 (200+ reviews)' badge sits above a Trustpilot widget whose rating we could not confirm.

    Visit Bodybuilding Health+
  • $165/mo semaglutide and $214/mo tirzepatide month to month, dropping to $97 and $177 on a 12-month plan — with a genuinely itemized exclusion list that explicitly screens out pregnancy, planned pregnancy, and breastfeeding rather than staying silent on it.

    Visit HealthRX

Providers like Maves

Keep comparing Maves

Maves, answered

How much does Maves cost?
At last review, Maves's lowest ongoing compounded rate was about $249/mo — $249/mo after $189 first month for semaglutide, $349/mo after $249 first month for tirzepatide. This market re-prices often, so check the current all-in figure at the source before committing.
Is Maves safe to use while breastfeeding?
None of these drugs is established as safe in pregnancy, so stopping before you try to conceive is the usual plan. Nursing is less clear-cut. The Wegovy injection, Ozempic, Zepbound and Mounjaro labels have little or no breast-milk data and ask you and your clinician to weigh the benefits of breastfeeding against how much you need the drug. Compounded versions carry no label of their own; ask the prescriber directly how they handle nursing patients. Maves is not an exception to any of that — settle the timing with your own clinician.
Does Maves offer both semaglutide and tirzepatide?
Yes — Maves offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
How does Maves score for mothers?
Maves scores 34/100 on our Metabolic-Fit Score, a weighted read of six things mothers actually have to care about. CoreAge Rx, a featured partner, is worth a side-by-side look.

Pricing, states and verification reflect Maves's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.

← Back to all providers